23 GHP Q3 2025 Circa Skin Limited (Circa Skin) delivers pioneering medical grade skincare, supported by exceptional training, marketing, and partnerships, in order to assist practitioners, all whilst delivering outstanding results to clients. Passionate about redefining skin health and aesthetic excellence through innovation, expertise, and care, whilst advocating sustainable skincare, Circa Skin’s portfolio of award-winning brands empowers clinics and practitioners across the UK and beyond with premium products and transformative results. The firm’s commitment to excellence is reflected in everything it undertakes, from its relentless drive for innovation to its unwavering focus on patient safety. Proud to be ISO 13485 certified for aesthetics, Circa Skin is dedicated to safe skincare and ensures that its products meet the highest standards of quality and regulatory compliance. Sustainability is also a core value which the company abides by, consciously designing its practices and packaging to reduce environmental impact. One of the company’s standout hero procedures is WOW fusion® - a cutting-edge, award-winning micro-needling device that merges micro‑needling, mesotherapy, and skin nutrition into one hyper‑personalised treatment. Featuring 20 ultra‑fine (0.13 mm) 24K gold‑plated needles, it delivers bespoke cocktails of actives - like hyaluronic acid, vitamins, antioxidants, and optional micro‑toxin - directly to the dermal‑epidermal junction. This precise infusion stimulates collagen, refines pores, restores hydration, brightens pigmentation, and reduces redness - all with minimal downtime and comfort akin to a gentle “stamping” sensation. With visibly proven results, WOW fusion® clients report radiant “glass skin,” visibly smoother texture, diminished pore size and less redness within days. Not only this, but treatment times are 45–60 minutes, with minimal discomfort and downtime, making it ideal as a ‘pre‑event glow’ protocol. Circa Skin prides itself on its safety protocols, training only qualified medical prescribers, such as doctors, dentists, and independent nurse/midwife prescribers, in the latest aesthetic techniques and procedures. In 2025, the Nursing and Midwifery Council (NMC) introduced new regulations mandating that all nurse and midwife prescribers perform face-to-face consultations before prescribing nonsurgical cosmetic medicines - such as botulinum toxin - effectively banning remote prescribing from 1st June 2025. This milestone aligns with broader government efforts to professionalise medical aesthetics and regulate prescribers and clinics, and alignment with these emerging standards has always been a guiding principle for Redefining the global aesthetics industry through transformative, science-led solutions that uphold safety, elevate wellbeing, and support the sustainable growth of ethical businesses is at the heart of every endeavour that Circa Skin Limited undertakes. Following its latest success in the Global Excellence Awards 2025, we find out more about the brand and its ethos from Founder and CEO, Claire Williams. The WOW Factor Circa Skin as it strictly follows prescribing protocols, ensuring every prescriber conducts an in-person consultation, comprehensive assessment, and obtains full medical history before treatment. Furthermore, this governance is underpinned by ISO 13485 certification, demonstrating the company’s unwavering commitment to compliance and safety. “We welcome the increased regulatory oversight,” Claire rejoices. “These standards mirror our core philosophy that patient safety and clinical integrity come first. The shift not only underscores our leadership role but also strengthens the entire medical aesthetics ecosystem by prioritising safe, evidence-led, and professional practice.” It comes as no surprise that Circa Skin celebrated success recently at the Global Excellence Awards as it was crowned Best HyperPersonalised Facial Treatment 2025 – UK for its safe administration of the WOW Facial treatments. Now, Claire and the team have their sights firmly fixed on what lies ahead in the aesthetics industry, with ongoing research in the emerging science of skin regeneration at the top of the list. “We believe the future of aesthetics lies in regenerative medicine - a shift from purely cosmetic enhancements to treatments that restore, rebuild, and reprogram skin health from within,” Claire states. “Our strategic direction for the next five years is to lead this transformation, both through innovative product development and advanced practitioner education. “We’re not just developing products - we’re shaping the future of skin health. With every formula we create, every training we deliver, and every practitioner we support, our purpose remains the same: to raise standards, protect patients, and empower professionals. As we lead the shift toward regenerative aesthetics, our focus is clear - to innovate with integrity, educate with purpose, and care with heart.” Contact: Claire Williams Company: Circa Skin Ltd/WOW Facial Ltd Web Address: www.circaskin.co.uk Jul25108
RkJQdWJsaXNoZXIy MTUyMDQwMA==